Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3385-3391

  Arrese, Marta ^a   Portela, Agustín ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS NUCLEOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0029934078     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.3385-3391.1996     Document Type: Article

References (46)

1. Albo, C., A. Valencia, and A. Portela. 1995. Identification of an RNA binding region within the N-terminal third of the influenza A virus nucleoprotein. J. Virol. 69:3799-3806.
2. Almond, J. W., and V. Felsenreich. 1982. Phosphorylation of the nucleoprotein of an avian influenza virus. J. Gen. Virol. 60:295-305.
3. Bárcens, J., M. Ochoa, S. de la Luna, J. A. Melero, A. Nieto, J. Ortín, and A. Portela. 1994. Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J. Virol. 68:6900-6909.
4. Barik, S., and A. K. Banerjee. 1992. Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J. Virol. 66:1109-1118.
5. Baudin, F., C. Bach, S. Cusak, and R. W. H. Ruigrok. 1994. Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J. 13:3158-3165.
6. Beaton, A. R., and R. M. Krug. 1986. Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 57prime; capped end. Proc. Natl. Acad. Sci. USA 83:6282-6286.
7. Compans, R. W., J. Content, and P. H. Duesberg. 1972. Structure of the ribonucleoprotein of influenza virus. J. Virol. 10:795-800.
8. Davey, J., N. J. Dimmock, and A. Colman. 1985. Identification of the sequence responsible for the nuclear accumulation of the influenza virus nucleoprotein in Xenopus oocytes. Cell 40:667-675.
9. de la Luna, S., C. Martínez, and J. Ortín. 1989. Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res. 13:143-156.
10. Duesberg, P. H. 1969. Distinct subunits of the ribonucleoprotein of influenza virus. J. Mol. Biol. 42:485-499.
11. Fanning, E. 1994. Control of SV40 DNA replication by protein phosphorylation: a model for cellular DNA replication? Trends Cell Biol. 4:250-255.
12. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
13. Gao, Y., and J. Lenard. 1995. Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase-II. EMBO J. 14:1240-1247.
14. García-Barreno, B., T. Delgado, B. Akerlind-Stopner, E. Norrby, and J. A. Melero. 1992. Location of the epitope recognized by monoclonal antibody 63G on the primary structure of human respiratory syncytial virus G glycoprotein and the ability of synthetic peptides containing this epitope to induce neutralizing antibodies. J. Gen. Virol. 73:2625-2630.
15. García-Sastre, A., and P. Palese. 1993. Genetic manipulation of negative-strand RNA virus genomes. Annu. Rev. Microbiol. 47:765-790.
16. Gorman, M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
17. Gregoriadis, A., T. Christie, and K. Markarian. 1984. The membrane (M1) protein of influenza virus occurs in two forms and is a phosphoprotein. J. Virol. 49:229-235.
18. Honda, A., K. Uev́da, K. Nagata, and A. Ishihama. 1988. RNA polymerase of influenza virus: role of NP in RNA chain elongation. J. Biochem. 104:1021-1026.
19. Kemp, B. E., and R. B. Pearson. 1990. Protein kinase recognition sequence motifs. Trends Biochem. Sci. 15:342-346.
20. Kingsbury, D. W., I. M. Jones, and K. G. Murti. 1987. Assembly of influenza ribonucleoprotein in vitro using recombinant nucleoprotein. Virology 156:396-403.
21. Kingsbury, D. W., and R. G. Webster. 1969. Some properties of influenza virus nucleocapsids. J. Virol. 4:219-225.
22. Kistner, O., H. Müller, H. Becht, and C. Scholtissek. 1985. Phosphopeptide fingerprints of nucleoproteins of various influenza A virus strains grown in different host cells. J. Gen. Virol. 66:465-472.
23. Kistner, O., K. Müller, and C. Scholtissek. 1989. Differential phosphorylation of the nucleoprotein of influenza A viruses. J. Gen. Virol. 70:2421-2431.
24. Kobayashi, M., T. Toyoda, D. M. Adyshev, V. Azuma, and A. Ishihama. 1994. Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding domain. J. Virol. 68:8433-8436.
25. Krug, R. M., F. V. Alonso-Caplen, I. Julkunem, and M. G. Katze. 1989. Expression and replication of the influenza virus genome, p. 89-152. In R. M. Krug (ed.), The influenza viruses. Plenum Press, New York.
26. Landon, M. Cleavage at aspartyl-prolyl bonds. Methods Enzymol. 47:145-149.
27. Lees-Miller, S. P., K. Sakaguchi, S. J. Ullrich, E. Appella, and C. W. Anderson. 1992. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactvation domain of human p53. Mol. Cell. Biol. 12:5041-5049.
28. López, J. A., M. Guillen, A. Sánchez-Fauquier, and J. A. Melero. 1986. An antigen-binding assay to determine the specificity of monoclonal antibodies against influenza virus and mapping of epitopes. J. Virol. Methods 13:255-264.
29. Mahy, B. W. J. 1983. Mutants of influenza virus, p. 192-242. In P. Palese and D. W. Kingsbury (ed.), Genetics of influenza viruses. Springer, Vienna.
30. Martin, J., C. Albo, J. Ortín, J. A. Melero, and A. Portela. 1992. In vitro reconstitution of active influenza virus ribonucleoprotein complexes using viral proteins purified from infected cells. J. Gen, Virol. 73:1855-1859.
31. Martin, K., and A. Helenius. 1991. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117-130.
32. Mena, I., S. de la Luna, C. Albo, J. Martín, A. Nieto, J. Ortín, and A. Portela. 1994. Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J. Gen. Virol. 75:2109-2114.
33. Mena, I., S. de la Luna, J. Martín, C. Albo, B. Perales, A. Nieto, A. Portela, and J. Ortín. 1995. Systems to express recombinant RNA molecules by the influenza virus A polymerase in vivo. Methods Mol. Genet. 7:329-342.
34. Petri, T., and N. J. Dimmock. 1981. Phosphorylation of influenza virus nucleoprotein in vivo. J. Gen. Virol. 57:185-190.
35. Pons, M. W., I. T. Schulze, G. K. Hirst, and R. Hauser. 1969. Isolation and characterization of the ribonucleoprotein of influenza virus. Virology 39:250-259.
36. Portela, A., L. D. Jones, and P. Nuttall. 1992. Identification of viral structural polypeptides of Thogoto virus (a tick-borne orthomyxo-like virus) and functions associated with the glycoprotein. J. Gen. Virol. 73:2823-2830.
37. Privalsky, M. L., and E. E. Penhoet. 1977. Phosphorylated protein component present in influenza virions. J. Virol. 24:401-405.
38. Privalsky, M. L., and E. E. Penhoet. 1978. Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc. Natl. Acad. Sci. USA 75:3625-3629.
39. Ruigrok, R. W. H., and F. Baudin. 1995. Structure of influenza virus ribonucleoprotein particles. II. Purified RNA-free influenza virus ribonucleoprotein forms structures that are indistinguishable from the intact influenza virus ribonucleoprotein particles. J. Gen. Virol. 76:1009-1014.
40. Sanz-Ezquerro, J. J., S. de la Luna, J. Ortín, and A. Nieto. 1995. Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J. Virol. 69:2420-2426.
41. Shapiro, G. I., and R. M. Krug. 1988. Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J. Virol. 62:2285-2290.
42. Takacs, A. M., S. Barik, T. Das, and A. K. Banerjee. 1992. Phosphorylation of specific serine residues within the acidic domain of phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. J. Virol. 66:5842-5848.
43. van Wyke, K. L., W. J. Bean, Jr., and R. G. Webster. 1981. Monoclonal antibodies to the influenza A virus nucleoprotein affecting RNA transcription. J. Virol. 39:313-317.
44. Whittaker, G., I. Kemler, and A. Helenius. 1995. Hyperphosphorylation of mutant influenza virus matrix protein. M1, causes its retention in the nucleus. J. Virol. 69:439-445.
45. Yamanaka, K., A. Ishihama, and K. Nagata. 1990. Reconstitution of influenza virus RNA-nucleoprotein complexes structurally resembling native viral ribonucleoprotein cores. J. Biol. Chem. 265:11151-11155.
46. Zvonarjev, A. Y., and Y. Z. Ghendon. 1980. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J. Virol. 33:583-586.